However, CP should be treated with more caution in prostate cancer therapy; increased activity of AR leads to increased sensitivity of prostate cancer cells to androgens, which in turn promotes PSA production, and high levels of PSA are often considered one of the indicative markers of prostate cancer. This evidence concerns the gene AR and prostate carcinoma.